The ASX200 is poised to open higher, reflecting Wall Street's positive momentum driven by a strong jobs report and easing trade tensions. While the term 'penny stock' might seem outdated, it still represents an intriguing investment area where smaller or newer companies can offer substantial opportunities. By focusing on those with robust financials and potential for growth, investors may uncover hidden gems within the market's lesser-known segments.
Top 10 Penny Stocks In Australia
| Name | Share Price | Market Cap | Rewards & Risks |
| CTI Logistics (ASX:CLX) | A$1.695 | A$136.52M | ✅ 4 ⚠️ 2 View Analysis > |
| Accent Group (ASX:AX1) | A$1.885 | A$1.07B | ✅ 4 ⚠️ 2 View Analysis > |
| EZZ Life Science Holdings (ASX:EZZ) | A$1.405 | A$66.28M | ✅ 4 ⚠️ 2 View Analysis > |
| IVE Group (ASX:IGL) | A$2.62 | A$403.96M | ✅ 4 ⚠️ 2 View Analysis > |
| GTN (ASX:GTN) | A$0.60 | A$115.38M | ✅ 3 ⚠️ 2 View Analysis > |
| West African Resources (ASX:WAF) | A$2.32 | A$2.64B | ✅ 4 ⚠️ 1 View Analysis > |
| Bisalloy Steel Group (ASX:BIS) | A$3.30 | A$156.59M | ✅ 3 ⚠️ 1 View Analysis > |
| Regal Partners (ASX:RPL) | A$2.06 | A$692.5M | ✅ 4 ⚠️ 3 View Analysis > |
| Navigator Global Investments (ASX:NGI) | A$1.65 | A$808.63M | ✅ 5 ⚠️ 3 View Analysis > |
| NRW Holdings (ASX:NWH) | A$2.73 | A$1.25B | ✅ 5 ⚠️ 1 View Analysis > |
Click here to see the full list of 988 stocks from our ASX Penny Stocks screener.
Underneath we present a selection of stocks filtered out by our screen.
Alligator Energy (ASX:AGE)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Alligator Energy Limited is involved in mineral exploration activities in Australia and Italy, with a market cap of A$120.10 million.
Operations: Alligator Energy Limited does not currently report any revenue segments.
Market Cap: A$120.1M
Alligator Energy, with a market cap of A$120.10 million, is currently pre-revenue and unprofitable, reporting losses of A$1.47 million for the half year ended December 2024. The company's financial stability is supported by short-term assets of A$21.1 million outweighing liabilities and a cash runway exceeding one year without debt reliance. Recent challenges include halted drilling at the Big Lake Uranium Project due to flooding in South Australia, impacting exploration timelines. Despite these setbacks, management's extensive experience may offer strategic resilience as earnings are forecasted to grow significantly annually despite current volatility in share price movements.
- Unlock comprehensive insights into our analysis of Alligator Energy stock in this financial health report.
- Gain insights into Alligator Energy's future direction by reviewing our growth report.
Biome Australia (ASX:BIO)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Biome Australia Limited focuses on the development, commercialization, and marketing of live biotherapeutics and complementary medicines both in Australia and internationally, with a market cap of A$108.56 million.
Operations: The company generates revenue of A$15.86 million from its segment dedicated to innovative evidence-based products that connect gut health with overall human wellness.
Market Cap: A$108.56M
Biome Australia, with a market cap of A$108.56 million, has shown promising financial progress by becoming profitable in the last year and reporting sales of A$8.86 million for H1 2025. The company's debt to equity ratio has improved over five years, and it holds more cash than total debt, although its operating cash flow remains negative. Short-term assets exceed both short-term and long-term liabilities, indicating financial stability. Recently added to the S&P/ASX Emerging Companies Index, Biome's earnings are forecasted to grow significantly annually despite low return on equity and high non-cash earnings levels impacting perceived quality.
- Click here to discover the nuances of Biome Australia with our detailed analytical financial health report.
- Examine Biome Australia's earnings growth report to understand how analysts expect it to perform.
Cobram Estate Olives (ASX:CBO)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Cobram Estate Olives Limited is involved in olive farming and the production and marketing of olive oil across Australia, the United States, and internationally, with a market cap of A$787.61 million.
Operations: The company's revenue segments include its US operations, which generated A$67.16 million.
Market Cap: A$787.61M
Cobram Estate Olives Limited, with a market cap of A$787.61 million, has demonstrated significant financial improvement. The company's half-year revenue rose to A$126.68 million, reducing its net loss from the previous year. Despite a high net debt to equity ratio of 78.3%, its interest payments are well covered by EBIT, and operating cash flow sufficiently covers debt obligations. Earnings have grown sharply by 104.8% over the past year, surpassing industry averages and indicating robust performance despite low return on equity and uncovered long-term liabilities by short-term assets valued at A$123 million.
- Take a closer look at Cobram Estate Olives' potential here in our financial health report.
- Assess Cobram Estate Olives' future earnings estimates with our detailed growth reports.
Seize The Opportunity
- Unlock our comprehensive list of 988 ASX Penny Stocks by clicking here.
- Interested In Other Possibilities? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Biome Australia might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com